Stratec SE (ETR:SBS – Get Free Report)’s share price traded down 0.9% during trading on Monday . The company traded as low as €17.78 and last traded at €17.80. 8,129 shares were traded during trading, an increase of 30% from the average session volume of 6,253 shares. The stock had previously closed at €17.96.
Stratec Price Performance
The company has a market capitalization of $213.84 million, a price-to-earnings ratio of 21.36, a P/E/G ratio of 10.43 and a beta of 0.80. The stock has a fifty day simple moving average of €17.63 and a 200-day simple moving average of €19.97. The company has a debt-to-equity ratio of 49.40, a current ratio of 4.33 and a quick ratio of 1.65.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Recommended Stories
- Five stocks we like better than Stratec
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
